How Effective Are Atypical Antipsychotics for Chronic Pain?
Olanzapine and quetiapine have gained attention as adjuncts in pain management regimens.
Therapies
Latest Therapies Articles
Effect of Group CBT on Preventing Weight Regain in Type 2 Diabetes
Over the long term, overweight and obese patients with type 2 diabetes often regain weight lost during weight loss programs.
ECT Associated Headaches Decreased With Preemptive Analgesia, Acetaminophen
ECT significantly reduced headache incidence and severity.
Clinical Hypnosis May Be Effective for Cancer Pain, IBS, Headaches
Results of brain imaging studies demonstrate that “hypnosis influences all of the cortical areas and neurophysiological processes that underlie pain and emotions.”
The ADA Issues Guidelines for Psychosocial Care in Diabetes
The ADA released detailed guidelines for psychosocial assessments and care based on factors including age, type of diabetes, and family support system.
Issues With Clinical Trials That Impede New Pain Drug Development
The major issues of drug development are that pre-clinical animal efficacy studies do not accurately predict human efficacy, and clinical trials often inaccurately fail to show drug efficacy.
Predicting Placebo Response May Now be Possible
Connectivity in the right midfrontal gyrus may help predict placebo response. This finding has widespread implications in drug development.
Crystal Structure of Cannabinoid Receptor 1 Determined: Implications for Managing Pain
The crystal structure may provide inspiration for designing drugs that refine efficacy and avoid adverse events.
Is Laughter Effective Complementary Medicine?
Laughing about 10 minutes every day has similar benefits to eating vegetables, exercising, and meditating.
Dialectical Behavioral Therapy for Managing Chronic Pain
Dialectical behavioral therapy uses the concept of “radical acceptance” to help manage the psychological and emotional aspects of chronic pain.
Drug News from MPR
Pharmacotherapy for Preschool-Age Children With ADHD Examined
Lumateperone Under Review for Bipolar Depression
Case Series: Naloxone Use Linked to Acute Pulmonary Edema
FDA Cracks Down on Companies Selling Unapproved CBD Products
Case Report: Pain Med Dose Linked to Patient’s Sleepwalking
FDA to Review Daridorexant for Insomnia Treatment
Azstarys, a Once-Daily Treatment for ADHD, Gets FDA Approval
Confirmatory Testing No Longer Needed for 23andMe’s CYP2C19 Report
FDA to Review Tasimelteon for Smith-Magenis Syndrome
FDA Approves Wakix For Excessive Daytime Sleepiness In Adults With Narcolepsy
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Therapies
